| Endoscopic treatment of high-risk bleeding ulcers: success, rebleeding and mortality. | |
| | |
MedLine Citation:
|
PMID: 18402332 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
INTRODUCTION AND AIMS: Endoscopic treatment of peptic ulcers with high-risk stigmata has been probed. The rates of recurrent bleeding, need for emergent surgery and death are related to Forrest Classification, Blatchford's modified risk score and the kind of endoscopic treatment used (monotherapy vs. dual). The aims of the present study were to report the success of endoscopic therapy in the reduction of the rate of initial success, recurrent bleeding, the need for surgery, and the mortality rate for patients with bleeding peptic ulcer and high-risk stigmata. PATIENTS AND METHODS: From a retrospective view, patients seen from September 2004 to March 2007 who had peptic ulcers Forrest Ia, Ib, IIa and/or IIb were included. RESULTS: Fifty-six patients were included (mean [SD] age 57.3 +/-16.6 years). The success rate was 91%, whilst the rest of the patients required immediate surgery. Recurrent bleeding was presented in 14 (27%) patients and eight (14.2%) required emergency surgery. The mortality rate was 3.6%. No factors were associated with the risk of failure to initial treatment, recurrent bleeding or need for surgery. The use of monotherapy by endoscopy was associated with the mortality. The variable "performed by a fellow alone" was not associated with any kind of outcome. CONCLUSION: Complication rate is similar to previous reports of general hospitals, but is higher than those of referral centers. Endoscopic monotherapy is associated with a major mortality risk. |
| | |
Authors:
|
Félix I Téllez-Avila; Norberto C Chávez-Tapia; Ada M Franco-Guzmán; Andrés Duarte-Rojo; Gustavo López-Arce; Jesús A Camacho; Miguel Angel Ramírez-Luna |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Revista de investigación clínica; organo del Hospital de Enfermedades de la Nutrición Volume: 59 ISSN: 0034-8376 ISO Abbreviation: Rev. Invest. Clin. Publication Date: 2007 Nov-Dec |
Date Detail:
|
Created Date: 2008-04-11 Completed Date: 2008-06-23 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9421552 Medline TA: Rev Invest Clin Country: Mexico |
Other Details:
|
Languages: eng Pagination: 419-23 Citation Subset: IM |
Affiliation:
|
Gastroenterology Departament, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Tlalpan, Mexico City. felixtelleza@gmail.com |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Aged Anti-Ulcer Agents / therapeutic use Blood Transfusion Combined Modality Therapy Electrocoagulation Emergencies Endoscopy, Gastrointestinal* / adverse effects, statistics & numerical data Epinephrine / administration & dosage, therapeutic use* Female Hemostatic Techniques* / adverse effects, instrumentation Humans Injections Laser Coagulation Male Middle Aged Peptic Ulcer / therapy* Peptic Ulcer Hemorrhage / mortality, therapy* Recurrence Retrospective Studies Risk Surgical Instruments |
| Chemical | |
Reg. No./Substance:
|
0/Anti-Ulcer Agents; 51-43-4/Epinephrine |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Viewpoint of the Dutch Melanoma Working Group regarding sentinel lymph node biopsy: prognostic but n...
Next Document: A single-institution, 20-year prospective experience with an affordable Fc-receptor blockade method ...